Episode Details

Can quality truly be inspected into a pharmaceutical product, or must it be built into the process from the very beginning?

In this episode of The GMP Insider, we examine the difference between Quality by Design (QbD) and Quality by Inspection, and why prevention is the foundation of sustainable pharmaceutical quality.

Discussion topics include:

• The philosophy behind Quality by Design
• Why inspection should confirm quality—not create it
• Process understanding and scientific knowledge as the basis for robust manufacturing
• Risk management and preventive controls
• Continuous monitoring and data-driven improvement
• Building systems that consistently deliver safe and effective products

Quality by Inspection focuses on finding problems after they occur.

Quality by Design focuses on understanding processes, reducing variability, and eliminating risks before they affect product quality.

The strongest pharmaceutical organizations recognize that inspections are not the primary quality control strategy—they are simply one checkpoint within a well-designed, well-controlled quality system.

Because lasting quality is achieved through prevention, not detection.

The best inspection finding is the one that never occurs because the system prevented the problem in the first place.